Abstract：
Perifoveal anomalous exudative vascular complex (PEVAC) was first described in 2011. Since then, individual clinical cases and a couple of case series have been published, and their characteristics have been studied in multi-modal images. To date, there is no consensus on its treatment. Initially, it was thought that PEVACs could be left to spontaneous evolution because they presented a slow progression. But it has been shown that the growth of the lesion covers a spectrum from non-exudative lesions to PEVAC with vision impairment over time. We present an updated bibliographic review of this pathology. We explain the changes in the diagnostic criteria that have been undergone. And we focus the discussion on selective treatment with focal laser, which has shown an excellent anatomical response and visual improvement or stabilization in the cases described and in our series of three patients systematically treated with focal laser. [Ophthalmic Surg Lasers Imaging Retina 2023;54:43-49.].
摘要：
2011年首次描述了中央凹异常渗出性血管复合体（PEVAC）。从那以后,已经发表了个别临床病例和几个病例系列，并在多模态图像中研究了它们的特征。迄今为止,对其治疗没有共识。最初，人们认为PEVACs可能会自发进化,因为它们的进展缓慢.但是已经表明，随着时间的推移，病变的生长涵盖了从非渗出性病变到PEVAC的范围。我们提供了该病理学的最新书目综述。我们解释了已经经历的诊断标准的变化。我们集中讨论了聚焦激光的选择性治疗，在所描述的病例中以及在我们用聚焦激光治疗的三名患者系列中，显示出出色的解剖学反应和视觉改善或稳定。[眼科手术激光成像视网膜2023；54：43-49。].
